Model for evaluating gastric cancer prognosis based on Lauren typing and postoperative residual lymph nodes and application
A lymph node and prognosis technology, applied in the field of biomedical detection, can solve problems such as inability to accurately guide prognosis and inability to accurately assess changes in the overall tumor burden of gastric cancer
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment
[0042] For example, the patient visited the doctor on June 1, 2020, aged 60, female. 2020-1-8 Diagnosis of locally advanced gastric adenocarcinoma, Lauren type diffuse type. 2020-1-20 Start DOS regimen neoadjuvant chemotherapy. Radical surgery for gastric cancer was performed on May 25, 2020. The postoperative pathology of the patient is as follows: (total gastric) ulcerative adenocarcinoma, cancer tissue infiltrates the submucosa of the gastric wall, tumor thrombi are seen in the vessels, fibrous tissue hyperplasia around the tumor, and inflammatory cell infiltration, consistent with the changes after treatment, residual tumor cells occupy the original tumor bed 80%, lymph nodes 0 / 31.
[0043] In this case, when the patient was diagnosed with gastric cancer, Lauren typed diffuse type, and the data index of the risk factor was 2 points.
[0044] In this case, the patient had 0 residual lymph nodes after radical gastrectomy, and the risk factor data index was 1 point.
[0045...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com